Klawans Hl
About
In The Last Decade
Klawans Hl
34 papers receiving 393 citations
Peers
Comparison fields: 5 of 75
- Neurology 195
- Cellular and Molecular Neuroscience 163
- Psychiatry and Mental health 93
- Clinical Psychology 77
- Cognitive Neuroscience 66
Countries citing papers authored by Klawans Hl
This map shows the geographic impact of Klawans Hl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klawans Hl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klawans Hl more than expected).
Fields of papers citing papers by Klawans Hl
This network shows the impact of papers produced by Klawans Hl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klawans Hl. The network helps show where Klawans Hl may publish in the future.
Co-authorship network of co-authors of Klawans Hl
This figure shows the co-authorship network connecting the top 25 collaborators of Klawans Hl. A scholar is included among the top collaborators of Klawans Hl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klawans Hl. Klawans Hl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Epidemiology and pathophysiology of tardive dyskinesias. | 19 |
| 2 | Pergolide mesylate: four years experience in Parkinson's disease. | 13 |
| 3 | Depression and cognitive changes in Parkinson's disease: a review. | 4 |
| 4 | L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. | 4 |
| 5 | The pharmacology of olivopontocerebellar atrophy. | 19 |
| 6 | A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. | 5 |
| 7 | Tourette-like symptoms following chronic neuroleptic therapy. | 17 |
| 8 | Compressive neuropathies in Tourette syndrome. | 4 |
| 9 | Parkinsonism: is your treatment appropriate? | 1 |
| 10 | Involuntary movement disorders--each has a meaning all its own. | 2 |
| 11 | Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapy. | 1 |
| 12 | Levodopa-induced dopaminergic hypersensitivity in the pathogenesis of psychiatric and neurologic disorders. | 6 |
| 13 | A pharmacological model of the pathophysioloyg of schizophrenia. | 2 |
| 14 | 5-Hydroxytryptophan induced behavior in intact guinea pigs. | 7 |
| 15 | Benign orgasmic cephalgia. | 4 |
| 16 | Neurologic manifestations of Paget's disease of the skull. | 10 |
| 17 | Neurologic examination in an elderly population. | 24 |
| 18 | "Catecholamines" in the brain. | 1 |
| 19 | Treatment of parkinsonism with L-dopa (study of 105 patients). | 28 |
| 20 | Delayed traumatic syringomyelia. | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.